causal
Analysis v1
Strong Support
For adults with type 2 diabetes and kidney problems, taking a weekly semaglutide shot (1.0 mg) can lower their chances of serious kidney or heart issues by about a quarter over 3.4 years — about 1 in every 20 people who take it will avoid a major problem.
82
0
Evidence from Studies
Supporting (1)
82
Community contributions welcome
82
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
Randomized Controlled Trial
Human
2024 Jul 11The study tested the exact same drug, dose, and patient group as described in the claim, and found it reduced serious kidney and heart problems by 24%, just like the claim says.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.